Danaher Corporation Welcomes Charles Lamanna to Its Board of Directors
On February 20, 2025, Danaher Corporation (NYSE: DHR) made an important announcement regarding the expansion of its Board of Directors. The company revealed the appointment of Charles Lamanna as a new board member, who will also contribute to the Board's Science & Technology Committee. Lamanna currently serves as Corporate Vice President at Microsoft, where he leads innovation in AI-powered business applications. His extensive experience is expected to significantly enhance Danaher's mission to leverage technology to improve human health.
Lamanna has played a pivotal role in developing various transformative technologies at Microsoft, overseeing the design and product development of solutions such as Power Platform, Dynamics 365, and Copilot Studio. His track record as a founder and former CEO of MetricsHub, a cloud management solution acquired by Microsoft, further attests to his innovative capabilities and leadership acumen.
Steven M. Rales, Danaher’s Chairman of the Board, expressed enthusiasm about Lamanna’s appointment, highlighting the strategic importance of embracing artificial intelligence in scientific and technological advancements. According to Rales, Lamanna's deep expertise and leadership will be invaluable as Danaher endeavors to tackle vital health challenges and deliver sustainable solutions to disparate global communities.
Danaher Corporation is a leading player in the life sciences and diagnostics sectors, with a steadfast commitment to accelerating the power of science and technology to enhance health outcomes. The company collaborates closely with its clients to address critical health challenges, utilizing advanced scientific methodologies and innovative technologies.
The presence of a tech-savvy individual like Lamanna on the Board aligns well with Danaher’s vision of fostering scientific excellence and continuous improvement. With approximately 63,000 associates worldwide, Danaher's commitment to improving life quality—while laying the groundwork for a healthier future—remains steadfast. The integration of Lamanna’s insights into the technological landscape will undoubtedly forge new pathways for Danaher, as it seeks to develop and deliver life-changing therapies more efficiently.
As global health challenges grow increasingly intricate, the intersection of technology and healthcare becomes more crucial. Danaher stands at the forefront of this intersection, and the addition of Charles Lamanna promises to strengthen its leadership in scientific innovation. For more information on Danaher Corporation and its commitment to enhancing human health, visit www.danaher.com.